skin conditions - Nursing Case Study
Pathophysiology
• Primary mechanism: Inflammation - Initiated by immune response triggers such as allergens, pathogens, or irritants, leading to erythema, swelling, and warmth due to increased blood flow and immune cell activity.
• Secondary mechanism: Barrier dysfunction - Compromised skin barrier results from disrupted keratinocyte function, increasing transepidermal water loss and susceptibility to infections and irritants.
• Key complication: Chronic inflammation can lead to tissue damage and scarring, while barrier dysfunction heightens the risk for secondary infections and exacerbates skin conditions.
Patient Profile
Demographics:
45-year-old male, construction worker
History:
• Key past medical history: Eczema, Type 2 Diabetes
• Current medications: Metformin, Hydrocortisone cream
• Allergies: Penicillin
Current Presentation:
• Chief complaint: Worsening rash and skin irritation on arms and legs
• Key symptoms: Itching, redness, swelling, increased skin sensitivity, small blisters forming
• Vital signs: Blood pressure 145/90 mmHg, heart rate 95 bpm, respiratory rate 18 breaths per minute, temperature 100.2°F
Section 1
As the case unfolds, the patient’s condition worsens, prompting further diagnostic evaluation. Laboratory tests reveal a significant elevation in C-reactive protein (CRP) levels at 10 mg/L, indicating systemic inflammation. Additionally, a complete blood count (CBC) shows a mild leukocytosis with a white blood cell count of 12,000 cells/mcL, suggestive of an underlying infectious process. Skin cultures from the blistered areas on the patient’s arms and legs test positive for Staphylococcus aureus, pointing to a secondary bacterial infection likely aggravated by the patient’s compromised skin barrier and pre-existing eczema.
In response to the new diagnostic findings, the healthcare team initiates an antibiotic regimen tailored to address the Staphylococcus aureus infection, avoiding penicillin due to the patient’s allergy. Clindamycin is prescribed, and the patient is educated on proper application techniques for both the antibiotic and hydrocortisone creams to minimize further irritation and promote healing. Despite these interventions, the patient's condition remains challenging due to his concurrent Type 2 Diabetes, which can impair wound healing and complicate the management of skin infections.
The patient’s status continues to require close monitoring, particularly given his elevated blood glucose levels, which are averaging around 180 mg/dL. These levels are suboptimal, potentially hindering the resolution of the infection and inflammation. The healthcare team considers optimizing the patient’s glycemic control through adjustments in his diabetes management plan, including dietary modifications and potential changes in his Metformin dosage. This holistic approach aims to address both immediate complications and underlying risk factors, ultimately improving his skin condition and overall health.
Section 2
As the patient continues on the prescribed regimen of Clindamycin and hydrocortisone cream, the healthcare team closely monitors his progress. Despite initial hopes for improvement, new complications arise. The patient begins to exhibit signs of increased systemic involvement, characterized by a low-grade fever of 100.4°F and persistent fatigue. During a routine assessment, the nurse notes that the erythema around the blistered areas has expanded, and there is increased warmth and tenderness, suggesting that the infection may not be adequately controlled. Additionally, the patient reports a new onset of pain and swelling in his lower extremities, raising concerns for potential cellulitis.
Concurrently, the patient's blood glucose levels remain problematic, with fluctuations between 180-220 mg/dL, despite efforts to enhance glycemic control through dietary changes and medication adjustments. These elevated levels continue to impede effective wound healing and augment the inflammatory response. A follow-up CBC reveals a further increase in the white blood cell count to 14,500 cells/mcL, reinforcing the suspicion of a worsening infectious process. The healthcare team considers the possibility of antibiotic resistance or the need for additional antimicrobial therapy, prompting a re-evaluation of the current treatment plan.
In light of these developments, a multidisciplinary meeting is convened to discuss the patient's care strategy. The team deliberates on the potential benefits of incorporating a broader-spectrum antibiotic and explores alternative methods to achieve better glycemic control. The endocrinologist suggests adding a short-acting insulin regimen to address acute hyperglycemia, while the dietitian emphasizes the importance of carbohydrate consistency in meal planning. These collaborative efforts aim to stabilize the patient's condition, prevent further complications, and facilitate recovery. The plan is communicated to the patient and family, ensuring they understand the importance of these interventions in managing both the infection and underlying diabetes effectively.
Section 3
As the healthcare team implements the revised treatment plan, the patient undergoes another series of diagnostic evaluations to gauge the efficacy of the new interventions. A follow-up culture and sensitivity test of the blistered areas is conducted to determine if antibiotic resistance is contributing to the inadequate response to Clindamycin. Results reveal the presence of methicillin-resistant Staphylococcus aureus (MRSA), which necessitates a change in antibiotic therapy. The infectious disease specialist recommends transitioning to intravenous vancomycin to more effectively target the resistant strain.
In parallel, the patient is started on a short-acting insulin regimen to better manage his fluctuating blood glucose levels. Over the next few days, there is a noticeable improvement in glycemic control, with readings stabilizing between 110-140 mg/dL. This improved metabolic state is expected to enhance the patient's immune response and support wound healing. The dietitian continues to work closely with the patient, providing education on carbohydrate counting and meal planning to maintain consistent blood glucose levels.
Despite these positive steps, the patient experiences new complications. He reports increased shortness of breath and mild chest discomfort. An urgent assessment is conducted, revealing that his oxygen saturation has dropped to 90% on room air, accompanied by subtle wheezing upon auscultation of the lungs. An arterial blood gas (ABG) analysis is performed, showing a pH of 7.35, PaCO2 of 48 mmHg, and PaO2 of 68 mmHg, indicating respiratory acidosis. These findings suggest the possibility of a developing pulmonary issue, prompting the team to investigate further with a chest X-ray and pulmonary consult to address this emerging concern.
Section 4
As the healthcare team delves into the patient's respiratory issues, a chest X-ray reveals bilateral infiltrates suggestive of an evolving pneumonia, likely secondary to the skin infection with MRSA. The pulmonary consult confirms these findings and recommends initiating supplemental oxygen therapy via nasal cannula at 2 L/min to improve oxygenation. Concurrently, the patient's vital signs are closely monitored, showing a heart rate of 102 bpm, blood pressure of 138/84 mmHg, and respiratory rate of 22 breaths per minute. Despite supplemental oxygen, the patient reports persistent dyspnea, and oxygen saturation remains borderline at 92%.
In response to these developments, the healthcare team decides to broaden the patient's antibiotic coverage to include linezolid, which offers better penetration into lung tissues, in conjunction with vancomycin. Additionally, a sputum culture is obtained to further refine the treatment strategy by identifying any potential secondary pathogens. The team also adjusts the patient's fluid balance and encourages the use of an incentive spirometer to promote lung expansion and reduce atelectasis risk.
Despite these interventions, the patient begins to exhibit signs of increased work of breathing, with the need to sit upright to improve comfort and ease. The interdisciplinary team, including respiratory therapy, is mobilized to optimize respiratory support, highlighting the importance of a comprehensive approach to care. The focus remains on controlling the underlying infection, ensuring adequate oxygenation, and preventing further respiratory decline, setting the stage for continued close monitoring and potential escalation of care if needed.
Section 5
As the patient continues to receive treatment, the healthcare team notes a change in patient status that warrants immediate attention. Over the next 24 hours, the patient's respiratory status deteriorates despite the supplemental oxygen and antibiotic therapy. The respiratory rate increases to 28 breaths per minute, indicating increased work of breathing. The patient develops nasal flaring and intercostal retractions, suggesting worsening respiratory distress. Moreover, the oxygen saturation drops to 88% on 2 L/min via nasal cannula, prompting the team to escalate oxygen therapy to high flow nasal cannula at 10 L/min. The patient remains tachycardic with a heart rate of 110 bpm and blood pressure now elevated at 145/90 mmHg, reflecting potential systemic stress.
Simultaneously, new diagnostic results from the sputum culture return, revealing the presence of Pseudomonas aeruginosa, a multidrug-resistant organism, complicating the treatment plan. In response, the healthcare team decides to further adjust the antibiotic regimen to include piperacillin-tazobactam, which offers broader coverage against gram-negative organisms, in combination with the ongoing linezolid and vancomycin therapy. The decision underscores the importance of adapting the treatment strategy based on evolving clinical data and microbial findings.
The interdisciplinary team continues to monitor the patient closely, recognizing the potential for further respiratory compromise. They prioritize continued respiratory support and infection control while reassessing the patient's fluid status to prevent fluid overload, which could exacerbate pulmonary edema. The team also initiates discussions regarding potential non-invasive ventilation should the patient's condition not stabilize, emphasizing the need for proactive planning in managing this complex case. As the patient's journey progresses, the focus remains on stabilizing respiratory function, optimizing antibiotic therapy, and preventing further complications.